Cordarone and Oedema upper limb - a phase IV clinical study of FDA data

Summary:

Oedema upper limb is reported as a side effect among people who take Cordarone (amiodarone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pepcid,.

The phase IV clinical study analyzes which people have Oedema upper limb when taking Cordarone. It is created by eHealthMe based on reports of 22,652 people who have side effects when taking Cordarone from the FDA, and is updated regularly.

What is Cordarone?

Cordarone has active ingredients of amiodarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 22,776 Cordarone users. Check the latest studies of Cordarone.

What is Oedema upper limb?

Oedema upper limb (swelling of arm) is found to be associated with 240 drugs and 58 conditions by eHealthMe. Check the latest studies of Oedema upper limb.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

22,652 people reported to have side effects when taking Cordarone.
Among them, 13 people (0.06%) have Oedema upper limb.

Could Cordarone cause Oedema upper limb?

Among these 13 people:

How long have people been on Cordarone when they have Oedema upper limb? *

What is the gender of people who have Oedema upper limb when taking Cordarone? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Oedema upper limb when taking Cordarone? *

What are other drugs people take besides Cordarone? *

What are other side effects people have besides Oedema upper limb? *

Weakness: 5 people, 38.46%
Injection Site Extravasation (flow of (blood or lymph) from injection site): 4 people, 30.77%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 3 people, 23.08%
Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 3 people, 23.08%
Skin Discoloration: 3 people, 23.08%
Gastric Ulcer (stomach ulcer): 2 people, 15.38%
Joint Pain: 2 people, 15.38%
Pleural Effusion (water on the lungs): 2 people, 15.38%
Cellulitis (infection under the skin): 2 people, 15.38%
Skin Warm: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Cordarone and have Oedema upper limb?

- Check whether Oedema upper limb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cordarone:

Cordarone (22,776 reports)

Browse all side effects of Cordarone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema upper limb:

Oedema upper limb (240 drugs)

Browse all the conditions that are associated with Oedema upper limb:

Oedema upper limb (58 conditions)

Related publications that referenced our studies

Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on amiodarone hydrochloride (the active ingredients of Cordarone) and Cordarone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.